Hong Kong · Delayed Price · Currency is HKD Charmacy Pharmaceutical Statistics
Total Valuation
HKG:2289 has a market cap or net worth of HKD 593.46 million. The enterprise value is 1.63 billion.
| Market Cap | 593.46M |
| Enterprise Value | 1.63B |
Important Dates
The next estimated earnings date is Tuesday, December 1, 2026.
| Earnings Date | Dec 1, 2026 |
| Ex-Dividend Date | May 27, 2026 |
Share Statistics
HKG:2289 has 108.00 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 108.00M |
| Shares Outstanding | 108.00M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 31.97% |
| Owned by Institutions (%) | n/a |
| Float | 27.00M |
Valuation Ratios
The trailing PE ratio is 10.92.
| PE Ratio | 10.92 |
| Forward PE | n/a |
| PS Ratio | 0.11 |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | 1.63 |
| P/OCF Ratio | 1.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.23, with an EV/FCF ratio of 4.49.
| EV / Earnings | 30.05 |
| EV / Sales | 0.30 |
| EV / EBITDA | 9.23 |
| EV / EBIT | 11.25 |
| EV / FCF | 4.49 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 2.38.
| Current Ratio | 1.09 |
| Quick Ratio | 0.65 |
| Debt / Equity | 2.38 |
| Debt / EBITDA | 9.41 |
| Debt / FCF | 4.57 |
| Interest Coverage | 2.30 |
Financial Efficiency
Return on equity (ROE) is 7.86% and return on invested capital (ROIC) is 5.93%.
| Return on Equity (ROE) | 7.86% |
| Return on Assets (ROA) | 2.12% |
| Return on Invested Capital (ROIC) | 5.93% |
| Return on Capital Employed (ROCE) | 18.98% |
| Weighted Average Cost of Capital (WACC) | 1.72% |
| Revenue Per Employee | 6.53M |
| Profits Per Employee | 65,736 |
| Employee Count | 827 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 5.35 |
Taxes
In the past 12 months, HKG:2289 has paid 22.10 million in taxes.
| Income Tax | 22.10M |
| Effective Tax Rate | 28.91% |
Stock Price Statistics
The stock price has increased by +0.83% in the last 52 weeks. The beta is -0.96, so HKG:2289's price volatility has been lower than the market average.
| Beta (5Y) | -0.96 |
| 52-Week Price Change | +0.83% |
| 50-Day Moving Average | 5.50 |
| 200-Day Moving Average | 6.03 |
| Relative Strength Index (RSI) | 12.39 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2289 had revenue of HKD 5.40 billion and earned 54.36 million in profits. Earnings per share was 0.50.
| Revenue | 5.40B |
| Gross Profit | 386.19M |
| Operating Income | 145.16M |
| Pretax Income | 76.47M |
| Net Income | 54.36M |
| EBITDA | 168.06M |
| EBIT | 145.16M |
| Earnings Per Share (EPS) | 0.50 |
Balance Sheet
The company has 624.66 million in cash and 1.66 billion in debt, with a net cash position of -1.04 billion or -9.63 per share.
| Cash & Cash Equivalents | 624.66M |
| Total Debt | 1.66B |
| Net Cash | -1.04B |
| Net Cash Per Share | -9.63 |
| Equity (Book Value) | 700.21M |
| Book Value Per Share | 6.48 |
| Working Capital | 321.27M |
Cash Flow
In the last 12 months, operating cash flow was 371.15 million and capital expenditures -6.98 million, giving a free cash flow of 364.17 million.
| Operating Cash Flow | 371.15M |
| Capital Expenditures | -6.98M |
| Depreciation & Amortization | 23.31M |
| Net Borrowing | -237.89M |
| Free Cash Flow | 364.17M |
| FCF Per Share | 3.37 |
Margins
Gross margin is 7.15%, with operating and profit margins of 2.69% and 1.01%.
| Gross Margin | 7.15% |
| Operating Margin | 2.69% |
| Pretax Margin | 1.42% |
| Profit Margin | 1.01% |
| EBITDA Margin | 3.11% |
| EBIT Margin | 2.69% |
| FCF Margin | 6.63% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 6.37%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 6.37% |
| Dividend Growth (YoY) | -29.74% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 234.64% |
| FCF Payout Ratio | 10.19% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 6.36% |
| Earnings Yield | 9.16% |
| FCF Yield | 61.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2289 has an Altman Z-Score of 1.57 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 6 |